Jerzy E. Tyczynski

1.5k total citations
38 papers, 1.1k citations indexed

About

Jerzy E. Tyczynski is a scholar working on Oncology, Genetics and Reproductive Medicine. According to data from OpenAlex, Jerzy E. Tyczynski has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 9 papers in Genetics and 9 papers in Reproductive Medicine. Recurrent topics in Jerzy E. Tyczynski's work include Global Cancer Incidence and Screening (13 papers), BRCA gene mutations in cancer (9 papers) and Cancer Risks and Factors (9 papers). Jerzy E. Tyczynski is often cited by papers focused on Global Cancer Incidence and Screening (13 papers), BRCA gene mutations in cancer (9 papers) and Cancer Risks and Factors (9 papers). Jerzy E. Tyczynski collaborates with scholars based in United States, France and Poland. Jerzy E. Tyczynski's co-authors include Donald Maxwell Parkin, Freddie Bray, Juozas Kurtinaitis, Aivars Stengrēvics, Witold Zatoński, Harry J. Khamis, Mati Rahu, Anna Torrång, Rino Bellocco and I Pleško and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Cancer.

In The Last Decade

Jerzy E. Tyczynski

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerzy E. Tyczynski United States 15 438 291 231 213 197 38 1.1k
Ashley Stuckey United States 25 648 1.5× 211 0.7× 384 1.7× 243 1.1× 218 1.1× 85 1.9k
Carol Kosary United States 16 391 0.9× 178 0.6× 88 0.4× 119 0.6× 279 1.4× 22 1.5k
Wendy R. Brewster United States 24 429 1.0× 269 0.9× 118 0.5× 134 0.6× 363 1.8× 77 1.9k
Lorraine Shack Canada 16 686 1.6× 215 0.7× 158 0.7× 111 0.5× 162 0.8× 51 1.3k
Akiko Ioka Japan 23 935 2.1× 568 2.0× 71 0.3× 147 0.7× 405 2.1× 53 1.7k
Niels Lyhne Christensen Denmark 10 547 1.2× 242 0.8× 74 0.3× 64 0.3× 219 1.1× 30 1.0k
Lauren C. Peres United States 16 417 1.0× 69 0.2× 116 0.5× 274 1.3× 102 0.5× 71 1.2k
Katharina Emrich Germany 21 751 1.7× 293 1.0× 39 0.2× 142 0.7× 277 1.4× 50 1.3k
Maja Primic‐Žakelj Slovenia 17 642 1.5× 243 0.8× 79 0.3× 69 0.3× 150 0.8× 37 1.2k
Torgil R. Möller Sweden 17 460 1.1× 349 1.2× 122 0.5× 111 0.5× 165 0.8× 29 1.3k

Countries citing papers authored by Jerzy E. Tyczynski

Since Specialization
Citations

This map shows the geographic impact of Jerzy E. Tyczynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy E. Tyczynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy E. Tyczynski more than expected).

Fields of papers citing papers by Jerzy E. Tyczynski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy E. Tyczynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy E. Tyczynski. The network helps show where Jerzy E. Tyczynski may publish in the future.

Co-authorship network of co-authors of Jerzy E. Tyczynski

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy E. Tyczynski. A scholar is included among the top collaborators of Jerzy E. Tyczynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy E. Tyczynski. Jerzy E. Tyczynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stenehjem, David D., Sudhir Unni, Hillevi Bauer, et al.. (2021). BRCA testing and outcomes in women with breast cancer. Breast Cancer Research and Treatment. 186(3). 839–850. 8 indexed citations
5.
Bookman, Michael A., Jerzy E. Tyczynski, Janet L. Espirito, Thomas W. Wilson, & Ancilla W. Fernandes. (2017). Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer. Gynecologic Oncology. 146(1). 58–63. 21 indexed citations
6.
Tyczynski, Jerzy E., et al.. (2017). Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer. Gynecologic Oncology. 146(1). 44–51. 12 indexed citations
7.
Cronin‐Fenton, Deirdre, Anders Kjærsgaard, Mette Nørgaard, et al.. (2017). Clinical outcomes of female breast cancer according to BRCA mutation status. Cancer Epidemiology. 49. 128–137. 9 indexed citations
8.
Unni, Sudhir, Rishi Deka, Jerzy E. Tyczynski, et al.. (2016). BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer – an observational cohort study. Journal of Ovarian Research. 9(1). 18–18. 8 indexed citations
9.
Ehlken, B., et al.. (2014). Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients. Value in Health. 17(7). A663–A663. 1 indexed citations
10.
Tyczynski, Jerzy E., et al.. (2012). Safety Assessment of an Anti-Obesity Drug (Sibutramine). Drug Safety. 35(8). 629–644. 7 indexed citations
11.
Khamis, Harry J., et al.. (2005). Comparison of Male and Female Breast Cancer Incidence Trends, Tumor Characteristics, and Survival. Annals of Epidemiology. 15(10). 773–780. 92 indexed citations
12.
Tyczynski, Jerzy E. & Hans J. Berkel. (2005). Long-term all-sites cancer mortality time trends in Ohio, USA, 1970–2001: differences by race, gender and age. BMC Cancer. 5(1). 136–136. 7 indexed citations
13.
Tyczynski, Jerzy E., Freddie Bray, Tiiu Aareleid, et al.. (2004). Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. International Journal of Cancer. 109(4). 598–610. 45 indexed citations
14.
Tyczynski, Jerzy E., I Pleško, Tiiu Aareleid, et al.. (2004). Breast cancer mortality patterns and time trends in 10 new EU member states: Mortality declining in young women, but still increasing in the elderly. International Journal of Cancer. 112(6). 1056–1064. 68 indexed citations
15.
Tyczynski, Jerzy E.. (2003). A plateau of breast cancer mortality in Poland - an impact of time periods or birth generations? A joinpoint regression and APC analysis of recent time trends. Nowotwory Journal of Oncology. 53(4). 398–398. 1 indexed citations
16.
Montanaro, Fabio, Freddie Bray, Valerio Gennaro, et al.. (2003). Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes & Control. 14(8). 791–803. 82 indexed citations
17.
Pinheiro, Paulo S., Jerzy E. Tyczynski, Freddie Bray, et al.. (2003). Cancer incidence and mortality in Portugal. European Journal of Cancer. 39(17). 2507–2520. 52 indexed citations
18.
Bray, Freddie, Jerzy E. Tyczynski, & Donald Maxwell Parkin. (2003). Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. European Journal of Cancer. 40(1). 96–125. 95 indexed citations
19.
Tyczynski, Jerzy E., et al.. (1994). Cancer mortality among Polish migrants to Australia. European Journal of Cancer. 30(4). 478–484. 20 indexed citations
20.
Zatoński, Witold, Jerzy E. Tyczynski, & Nikolaus Becker. (1989). Geographical Distribution of Cancer in Poland. Recent results in cancer research. 114. 176–195. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026